BeigelJHTomashekKMDoddLE, et al. Remdesivir for the treatment of Covid-19 – preliminary report. N Eng J Med. Epub ahead of print 8October2020. DOI: 10.1056/NEJMoa2007764.
3.
World Health Organization. Guidance for managing ethical issues in infectious disease outbreaks. World Health Organization Library, 2016. https://apps.who.int/iris/handle/10665/250580
4.
ChinAWHChuJTSPereraMRA, et al. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe2020; 1(1): e10.
5.
MoorcraftSYMarriottCPeckittC, et al. Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey. Trials2016; 17(1): 17.
6.
DenningESharmaSSmolskisM, et al. Reported consent processes and demographics: a substudy of the INSIGHT strategic timing of antiretroviral treatment (START) trial. HIV Med2015; 16(Suppl 1): 24–29.
GobatNButlerCCMollisonJ, et al. What the public think about participation in medical research during an influenza pandemic: an international cross-sectional survey. Public Health2019; 177: 80–94.
11.
Van BortelTBasnayakeAWurieF, et al. Psychosocial effects of an Ebola outbreak at individual, community and international levels. Bull World Health Organ2016; 94(3): 210–214.
12.
FinebergHV. Pandemic preparedness and response – lessons from the H1N1 Influenza of 2009. N Engl J Med2014; 370(14): 1335–1342.